Zhong, Y., Liu, J., Li, X., Westin, S. N., Malpica, A., Lawson, B. C., . . . Fleming, N. D. (2021). A Modified 2 Tier Chemotherapy Response Score (CRS) and Other Histopathologic Features for Predicting Outcomes of Patients with Advanced Extrauterine High-Grade Serous Carcinoma after Neoadjuvant Chemotherapy. Cancers (Basel).
Citação norma ChicagoZhong, Yanping, et al. "A Modified 2 Tier Chemotherapy Response Score (CRS) and Other Histopathologic Features for Predicting Outcomes of Patients With Advanced Extrauterine High-Grade Serous Carcinoma After Neoadjuvant Chemotherapy." Cancers (Basel) 2021.
Deismireacht MLAZhong, Yanping, et al. "A Modified 2 Tier Chemotherapy Response Score (CRS) and Other Histopathologic Features for Predicting Outcomes of Patients With Advanced Extrauterine High-Grade Serous Carcinoma After Neoadjuvant Chemotherapy." Cancers (Basel) 2021.